tiprankstipranks
First Wave BioPharma announces publication of research on celiac disease
PremiumThe FlyFirst Wave BioPharma announces publication of research on celiac disease
9M ago
Meet First Wave BioPharma: Exclusive interview with CEO James Sapirstein
Premium
The Fly
Meet First Wave BioPharma: Exclusive interview with CEO James Sapirstein
9M ago
First Wave BioPharma ‘way undervalued,’ CEO Sapirstein says
Premium
The Fly
First Wave BioPharma ‘way undervalued,’ CEO Sapirstein says
9M ago
First Wave BioPharma announces acceptance of two abstracts on celiac disease
PremiumThe FlyFirst Wave BioPharma announces acceptance of two abstracts on celiac disease
10M ago
First Wave BioPharma price target lowered to $36 from $40 at Roth MKM
Premium
The Fly
First Wave BioPharma price target lowered to $36 from $40 at Roth MKM
10M ago
First Wave Bio Merges with ImmunogenX, Eyes Celiac Breakthrough
Premium
Company Announcements
First Wave Bio Merges with ImmunogenX, Eyes Celiac Breakthrough
10M ago
First Wave BioPharma price target set at $40 at Roth MKM
PremiumThe FlyFirst Wave BioPharma price target set at $40 at Roth MKM
1y ago
First Wave BioPharma Inc trading resumes
Premium
The Fly
First Wave BioPharma Inc trading resumes
1y ago
First Wave BioPharma Inc trading halted, volatility trading pause
Premium
The Fly
First Wave BioPharma Inc trading halted, volatility trading pause
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100